The challenge of choosing the correct biologic for the correct asthma patient.
作者信息
Sriaroon Panida, Casale Thomas B
机构信息
USF/All Children's Hospital Allergy/Immunology clinic, Tampa, Florida.
University of South Florida, Morsani College of Medicine, Dept of Medicine, Tampa, Florida.
出版信息
Ann Allergy Asthma Immunol. 2018 Oct;121(4):385-386. doi: 10.1016/j.anai.2018.08.012.
PMID:30290891
Abstract
摘要
相似文献
1
The challenge of choosing the correct biologic for the correct asthma patient.为合适的哮喘患者选择正确生物制剂的挑战。
Ann Allergy Asthma Immunol. 2018 Oct;121(4):385-386. doi: 10.1016/j.anai.2018.08.012.
2
The Role of Biologics in the Treatment of Nasal Polyps.生物制剂在鼻息肉治疗中的作用。
Immunol Allergy Clin North Am. 2020 May;40(2):295-302. doi: 10.1016/j.iac.2019.12.006. Epub 2020 Jan 8.
3
The use of biologic therapies for the management of pediatric asthma.生物疗法在小儿哮喘管理中的应用。
Pediatr Pulmonol. 2020 Mar;55(3):803-808. doi: 10.1002/ppul.24613. Epub 2019 Dec 27.
4
[Biotherapies for the treatment of asthma: are they the treatment of the future?].[用于治疗哮喘的生物疗法：它们是未来的治疗方法吗？]
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S44-10S48.
5
Severe asthma in the US population and eligibility for mAb therapy.美国人群中的重度哮喘及单克隆抗体疗法的适用性
J Allergy Clin Immunol. 2020 Apr;145(4):1295-1297.e6. doi: 10.1016/j.jaci.2019.12.009. Epub 2019 Dec 19.
6
Omalizumab as add-on therapy to inhaled steroids for asthma.奥马珠单抗作为吸入性糖皮质激素治疗哮喘的附加疗法。
Issues Emerg Health Technol. 2004 Jun(58):1-4.
7
[Omalizumab. A monoclonal antibody against IgE].奥马珠单抗。一种抗IgE单克隆抗体。
Med Monatsschr Pharm. 2004 Dec;27(12):404-7.
8
Selecting the right biologic for your patients with severe asthma.为严重哮喘患者选择合适的生物制剂。
Ann Allergy Asthma Immunol. 2018 Oct;121(4):406-413. doi: 10.1016/j.anai.2018.07.033. Epub 2018 Jul 27.
9
A New Monoclonal Antibody Treats Severe Asthma.一种新型单克隆抗体可治疗重度哮喘。
Am J Nurs. 2016 Jul;116(7):24-5. doi: 10.1097/01.NAJ.0000484935.48100.ce.
10
[PERSONALIZED TREATMENT OF ASTHMA: THE ISSUE OF ANTI-INTERLEUKIN-5 ANTIBODIES].[哮喘的个性化治疗：抗白细胞介素-5抗体问题]
Rev Med Liege. 2015 May-Jun;70(5-6):306-9.
Zotero 插件